H11018—Psychiatry and Behavioral Neurobiology

Contact:

Mentor Karen Cropsey, Psy.D., Associate Professor, Department of Psychiatry and Behavioral Neurobiology, University of Alabama School of Medicine 
401 Beacon Parkway West, Birmingham, AL 35209 (205) 916-0135 x505
This email address is being protected from spambots. You need JavaScript enabled to view it.


UNIVERSITY OF ALABAMA AT BIRMINGHAM (UAB) Department of Psychiatry is recruiting a Postdoctoral Fellow: The Psychiatry Department at UAB invites applications for a postdoctoral position with research interests in one of the following areas:  mood disorders, schizophrenia, or substance abuse.  Ongoing NIH projects include studies using combination pharmacotherapy and behavioral therapy for nicotine and substance abuse with criminal justice-involved participants, neuroimaging for smoking cessation among individuals with schizophrenia, and studies of treatment response in schizophrenia. Opportunities to gain experience in both neuroimaging as well as clinical trials is available. The fellow would be expected to participate in writing NIH grants as well as papers for publication from existing data sets and ongoing projects. Mentoring in grant writing and publications is available to transition the fellow to an independent scientist position in an academic medical setting. The post-doctoral candidate must be a doctoral level clinical or counseling psychologist (Alabama license or license-eligible after post-doc) who is dedicated to an academic medical research career in one of the above mentioned areas. In addition to writing papers and grants, the fellow would be expected to participate as a member of a team of psychologists and physicians conducting clinical research, as well as participate in limited clinical responsibilities necessary for licensure. Excellent writing and communication skills are essential, as well as a dedication to working with underserved and stigmatized client populations.

Please forward a letter of interest and CV to Dr. Karen Cropsey, Associate Professor, UAB Department of Psychiatry and Behavioral Neurobiology, Email: This email address is being protected from spambots. You need JavaScript enabled to view it. . Women and members of minority groups are especially encouraged to apply.

UAB News

  • As kids prepare to head back to school, required immunizations are typically on the to-do list, but getting potentially lifesaving vaccines should not end when adulthood begins, says one University of Alabama at Birmingham infectious diseases expert.

  • effrey R. Curtis, M.D., from the University of Alabama at Birmingham, and colleagues utilized 1998 to 2011 data from the U.S. Veterans Health Administration to identify RA patients initiating rituximab, abatacept, or anti-tumor necrosis factor (anti-TNF) therapy. The authors sought to assess the comparative risk of hospitalized infection associated with anti-TNF and non-anti-TNF biologic agents.

UAB Research News

  • New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.Written by Matt Windsor An enzyme closely associated with genetic forms of Parkinson’s disease appears to play a larger role in its progression than previously thought, say investigators at the University of Alabama at Birmingham. The new research offers encouraging evidence that drugs to block this enzyme, known as leucine-rich repeat kinase 2 or LRRK2, could slow — or even...

  • UAB School of Nursing's federally funded study shows both the patient and caregiver benefit from early palliative care.The earlier a specific phone-based, palliative care support program can be introduced to caregivers, the better they will be able to cope with the caregiving experience, according to research conducted by University of Alabama at Birmingham School of Nursing investigators. The patient outcomes from the study, known as ENABLE III, were presented June 3 at the American Society of...